Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease-Reference-Cited by-同舟云学术

Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease

Published:2022-08-31 Issue:4 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Boyd Kathryn¹²,Kouamou Vinie¹²^ORCID,Hlupeni Admire¹,Tangwena Zorodzai¹²,Ndhlovu Chiratidzo E.¹²,Makadzange Azure T.¹^ORCID,

Affiliation:

1. Charles River Medical Group, Harare, Zimbabwe

2. Unit of Internal Medicine, Department of Primary Health Care Sciences, University of Zimbabwe, Harare, Zimbabwe

Abstract

Cryptococcal disease (CD) remains a leading cause of morbidity and mortality among individuals with advanced HIV disease (AHD). Identifying point of care (POC) approaches to screening for CD in asymptomatic individuals is important to guide therapeutic management.

Funder

HHS | Centers for Disease Control and Prevention

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01075-22

Reference29 articles.

1. World Health Organization. 2017. Managing advanced HIV disease and rapid initiation of antiretroviral therapy. WHO, Geneva, Switzerland.

2. Concurrent advanced HIV disease and viral load suppression in a high-burden setting: Findings from the 2015–6 ZIMPHIA survey

3. World Health Organization. 2018. Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018: supplement to the 2016 consolidated guidelines of the use of antiretroviral drugs for treating and preventing HIV infection. WHO, Geneva, Switzerland.

4. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

5. Key highlights from the international AIDS society (IAS) conference 2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic testing and laboratory equity in clinical microbiology;Microbiology Spectrum;2024-08-06

2. Finger-Prick Whole Blood Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of Cryptococcosis in HIV-Negative Patients: A Case Series Study in Two Tertiary Centers in São Paulo, Brazil;Journal of Fungi;2023-11-25

3. Simplified regimens for AIDS-related cryptococcal meningitis – improving its access in Africa;AIDS;2023-10-26

4. High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency department;Medical Mycology;2023-09-01